Surmodics, Inc (SRDX)

Etorro trading 970x250
Surmodics, Inc (SRDX) Logo

About Surmodics, Inc

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The Vitro Diagnostics segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota. Address: 9924 West 74th Street, Eden Prairie, MN, United States, 55344

Surmodics, Inc News and around…

Latest news about Surmodics, Inc (SRDX) common stock and company :

Surmodics (SRDX) Beats on Q2 Earnings, Revises FY22 View
29 Apr, 2022 Yahoo! Finance

Despite solid IVD revenues, Surmodics (SRDX) reports a soft Q2 overall top line.

SurModics (SRDX) Reports Q2 Loss, Tops Revenue Estimates
27 Apr, 2022 Yahoo! Finance

SurModics (SRDX) delivered earnings and revenue surprises of 31.25% and 6.99%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Recap: Surmodics Q2 Earnings
27 Apr, 2022 FinancialContent

Surmodics (NASDAQ:SRDX) reported its Q2 earnings results on Wednesday, April 27, 2022 at 07:30 AM. Here's what ...

Surmodics Reports Second Quarter Fiscal 2022 Results
27 Apr, 2022 FinancialContent

Surmodics Reports Second Quarter Fiscal 2022 Results

Pounce™ Thrombectomy System First-in-Human Data Show 100 Percent Technical Success in Early Cases
27 Apr, 2022 FinancialContent

Pounce™ Thrombectomy System First-in-Human Data Show 100 Percent Technical Success in Early Cases

Earnings Scheduled For April 27, 2022
27 Apr, 2022 FinancialContent

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first ...

Dr. Gary Ansel to Present Pounce™ Thrombectomy System First-in-Human Data at Charing Cross Symposium
25 Apr, 2022 FinancialContent

Dr. Gary Ansel to Present Pounce™ Thrombectomy System First-in-Human Data at Charing Cross Symposium

Surmodics Q2 2022 Earnings Conference Call On April 27, 2022 At 08:30 AM ET
20 Apr, 2022 FinancialContent

Surmodics (NASDAQ:SRDX) will host a conference call at 08:30 AM ET on April 27, 2022, to discuss Q2 2022 earnings results. How to ...

Surmodics to Webcast Second Quarter Fiscal 2022 Earnings Conference Call on April 27
19 Apr, 2022 FinancialContent

Surmodics to Webcast Second Quarter Fiscal 2022 Earnings Conference Call on April 27.

Should You Be Adding Surmodics (NASDAQ:SRDX) To Your Watchlist Today?
16 Apr, 2022 Yahoo! Finance

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...

Reasons to Add Surmodics (SRDX) Stock to Your Portfolio
22 Mar, 2022 Yahoo! Finance

Investors continue to be optimistic about Surmodics (SRDX) owing to its consistent efforts to boost R&D.

Those who invested in Surmodics (NASDAQ:SRDX) five years ago are up 83%
21 Mar, 2022 Yahoo! Finance

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...

OMFS's Holdings Imply 14% Gain Potential
17 Mar, 2022 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Russell 2000—Dynamic Multifactor ETF (OMFS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $44.69 per unit.

Analysts Anticipate 41% Upside For PSCH
14 Feb, 2022 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco S&P SmallCap Health Care ETF (PSCH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $225.32 per unit.

Surmodics to Host Virtual Annual Meeting of Shareholders
04 Feb, 2022 FinancialContent

Surmodics to Host Virtual Annual Meeting of Shareholders on February 10, 2022 at 4:00 p.m. (CT)

Increases to Surmodics, Inc.'s (NASDAQ:SRDX) CEO Compensation Might Cool off for now
04 Feb, 2022 Yahoo! Finance

In the past three years, the share price of Surmodics, Inc. ( NASDAQ:SRDX ) has struggled to grow and now shareholders...

12 Health Care Stocks Moving In Thursday's Intraday Session
03 Feb, 2022 FinancialContent

Gainers SOC Telemed (NASDAQ:TLMD) shares increased by 333.5% to $2.79 during Thursday's regular session. Trading ...

Stocks That Hit 52-Week Lows On Thursday
03 Feb, 2022 FinancialContent

On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And ...

SurModics (SRDX) Reports Q1 Loss, Misses Revenue Estimates
03 Feb, 2022 Yahoo! Finance

SurModics (SRDX) delivered earnings and revenue surprises of 63.89% and 3.47%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Surmodics: Q1 Earnings Insights
03 Feb, 2022 FinancialContent

Surmodics (NASDAQ:SRDX) reported its Q1 earnings results on Thursday, February 3, 2022 at 07:30 AM. Here's what ...

Surmodics Reports First Quarter Fiscal 2022 Results
03 Feb, 2022 FinancialContent

Surmodics Reports First Quarter Fiscal 2022 Results

Earnings Scheduled For February 3, 2022
03 Feb, 2022 FinancialContent

Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second ...

Analysts Estimate SurModics (SRDX) to Report a Decline in Earnings: What to Look Out for
27 Jan, 2022 Yahoo! Finance

SurModics (SRDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Surmodics to Webcast First Quarter Fiscal 2022 Earnings Conference Call on February 3
26 Jan, 2022 FinancialContent

Surmodics to Webcast First Quarter Fiscal 2022 Earnings Conference Call on February 3. Webcast is Live at 7:30 a.m. (CT)

Sidoti Winter Virtual Small Cap Investor Conference
18 Jan, 2022 Yahoo! Finance

* Presentation Times and Weblinks Released for Over 70 Presenting Companies * Wednesday and Thursday, January 19th-20th, 2022NEW YORK, NY / ACCESSWIRE / January 18, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day January Small Cap Virtual Conference taking place Wednesday and Thursday, January 19th-20th, 2022. The links can also be found at www.

Surmodics to Present at Sidoti & Company Virtual Investor Conference
11 Jan, 2022 FinancialContent

Surmodics to Present at Sidoti & Company Virtual Investor Conference on January 19, 2022.

Miromatrix Announces Two New Board Members
05 Jan, 2022 Yahoo! Finance

EDEN PRAIRIE, Minn., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced the expansion of the board and appointment of two new board members: Lisa Wipperman Heine and William P. Burke. "I am thrilled to welcome Lisa and Bill to the Miromatrix Board as we continue developing bioengineered organs to address the transpla

Surmodics (NASDAQ:SRDX) Could Easily Take On More Debt
30 Dec, 2021 Yahoo! Finance

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

Are Surmodics, Inc.'s (NASDAQ:SRDX) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
24 Nov, 2021 Yahoo! Finance

Surmodics (NASDAQ:SRDX) has had a rough month with its share price down 12%. It seems that the market might have...

Surmodics Inc (SRDX) Q4 2021 Earnings Call Transcript
10 Nov, 2021 FinancialContent

SRDX earnings call for the period ending September 30, 2021.

Surmodics, Inc (SRDX) is a NASDAQ Common Stock listed in , ,

970x250